Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (181-190 of 361) with videos related to

Pageof 37
Sort By:
NPJ Breast Cancer|November 12, 2022
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancerIgor Makhlin, Nicholas P McAndrew, E Paul Wileyto, et al.
Carcinogenesis|February 24, 2012
Evaluation of 19 susceptibility loci of breast cancer in women of African ancestryDezheng Huo, Yonglan Zheng, Temidayo O Ogundiran, et al.
Breast Cancer Research and Treatment|April 4, 2014
Long-term risk of medical conditions associated with breast cancer treatmentDeirdre A Hill, Nora K Horick, Claudine Isaacs, et al.
JAMA Oncology|April 30, 2026
Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical TrialKim A Reiss, Mingyi Xia, Mwangala Akamandisa, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian CancerStephanie L Wethington, Payal D Shah, Lainie Martin, et al.
JAMA|July 14, 2011
Clinically relevant changes in family history of cancer over timeArgyrios Ziogas, Nora K Horick, Anita Y Kinney, et al.
The Journal of Urology|March 28, 2023
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer PatientsKelsey E Breen, Heather Symecko, Kelsey Spielman, et al.
Nature Communications|November 7, 2022
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, et al.
Nature Communications|April 9, 2026
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classificationChunling Hu, Sounak Sahu, Wenan Chen, et al.
Pageof 37

Showing results (181-190 of 361) with videos related to

Sort By:
Pageof 37
NPJ Breast Cancer|November 12, 2022
Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancerIgor Makhlin, Nicholas P McAndrew, E Paul Wileyto, et al.
Carcinogenesis|February 24, 2012
Evaluation of 19 susceptibility loci of breast cancer in women of African ancestryDezheng Huo, Yonglan Zheng, Temidayo O Ogundiran, et al.
Breast Cancer Research and Treatment|April 4, 2014
Long-term risk of medical conditions associated with breast cancer treatmentDeirdre A Hill, Nora K Horick, Claudine Isaacs, et al.
JAMA Oncology|April 30, 2026
Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical TrialKim A Reiss, Mingyi Xia, Mwangala Akamandisa, et al.
JCO Precision Oncology|May 26, 2021
Integrating Clinical and Polygenic Factors to Predict Breast Cancer Risk in Women Undergoing Genetic TestingElisha Hughes, Placede Tshiaba, Susanne Wagner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian CancerStephanie L Wethington, Payal D Shah, Lainie Martin, et al.
JAMA|July 14, 2011
Clinically relevant changes in family history of cancer over timeArgyrios Ziogas, Nora K Horick, Anita Y Kinney, et al.
The Journal of Urology|March 28, 2023
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer PatientsKelsey E Breen, Heather Symecko, Kelsey Spielman, et al.
Nature Communications|November 7, 2022
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, et al.
Nature Communications|April 9, 2026
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classificationChunling Hu, Sounak Sahu, Wenan Chen, et al.
Pageof 37